Hjem › Akut myelogen leukemi › New Jersey › Newark
Kliniske studier for Akut myelogen leukemi i Newark, NJ
12 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Newark (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Morristown Medical Center, Morristown · 17 mi unna
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Cooperman Barnabas Medical Center, Livingston · 9 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Newark Beth Israel Medical Center, Newark
- Morristown Medical Center, Morristown · 17 mi unna
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekruttererFase 1/2
- Atlantic Health, Morristown · 17 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Morristown Medical Center, Morristown · 17 mi unna
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- Morristown Medical Center, Morristown · 17 mi unna
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
RekruttererFase 2/3
- Atlantic Health, Morristown · 17 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Atlantic Health, Morristown · 17 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Newark
- Brystkreft18 studier
- Ryggmargsskader13 studier
- Ikke-småcellet lungekreft13 studier
- Hjertesvikt10 studier
- Metastatisk kreft10 studier
- Kardiovaskulær sykdom9 studier
- Pankreaskreft9 studier
- Melanom8 studier
- Kreft (alle typer)7 studier
- Lungekreft7 studier
- Crohns sykdom7 studier
- Stenose i aortaklaffen6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.